FORMULATION AND DEVELOPMENT OF TRAMODOL HYDROCHLORIDE EXTENDED RELEASE TABLETS by Selvaraj, Balakrishnana & Shanmugapandiyan, Pitchaimuthunadar
Selvaraj et al                                Journal of Drug Delivery & Therapeutics; 2013, 3(4), 72-78    72 
© 2011, JDDT. All Rights Reserved                                                        ISSN: 2250-1177                                                     CODEN (USA): JDDTAO 
 
Available online at http://jddtonline.info 
RESEARCH ARTICLE 
FORMULATION AND DEVELOPMENT OF TRAMADOL HYDROCHLORIDE 
EXTENDED RELEASE TABLETS 
Selvaraj Balakrishnan
a
, 
*
Shanmugapandiyan Pitchaimuthunadar
b 
aPrist University, Thanjavur - 613403, Tamilnadu, India 
bKVK College of Pharmacy, Surmaiguda, Hyderabad, Andrapradesh, India 
*Corresponding Author’s Fax No: 040-24201993, Mobile No: 09952923477, Email: shanmugapandiyan@gmail.com 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
Analgesics are drugs which provide symptomatic relief 
from painful conditions. These drugs are very often 
consumed by patients suffering from acute and chronic 
pains. However these drugs are not consumed by patients 
as per prescription advice. Patients very often miss a dose 
and compliance to dosage regimen always remains a 
question mark. To overcome these kinds of issues and also 
to maintain a continuous therapeutic level of drugs in 
systemic circulation, extended release tablets come in 
handy as a solution. 
Tramadol Hydrochloride is an opiod analgesic drug which 
draws attention in the treatment of osteoarthritis.  It is a 
centrally acting drug and blocks the transmission of pain 
signals sent by nerves to the brain. It is freely soluble in 
water and hence becomes an ideal candidate for 
formulating extended release tablets
1
. It is white or almost 
white crystalline powder in nature.  
An attempt was made in this study to prepare and evaluate 
extended release matrix tablets of Tramadol Hydrochloride 
by employing Hydroxy propyl cellulose, Ethyl Cellulose, 
Hydroxy propyl methyl cellulose K100 and Chitosan as 
rate retarding polymers in various combinations and 
proportions. 
 
MATERIALS AND METHODS 
M/s. Stedman Pharmaceuticals Pvt Ltd., Chennai provided 
Tramadol Hydrochloride BP as gift sample for this study. 
M/s. Safetab Life Science, Pondicherry was kind enough 
to provide required quantities of polymers / excipients 
including Hydroxy propyl cellulose, Ethyl Cellulose, 
Hydroxy propyl methyl cellulose K100, Di calcium 
phosphate, Colloidal silicon dioxide and Magnesium 
Stearate. Chitosan (Chitopharm M) was a gift sample from 
M/s Cognis. All other materials, reagents and solvents 
used in this study were of analytical grade. 
Preparation of Extended Release Matrix Tablets 
The drug, Tramadol Hydrochloride and excipients were 
subjected to preformulation studies for characterization. 
All the raw materials comprising Tramadol Hydrochloride, 
rate retarding polymers in various combinations & 
proportions and excipients including Dicalcium phosphate, 
Magnesium stearate and Colloidal silicon dioxide were 
passed through sieve No 30 and thoroughly mixed to form 
a uniform matrix blend. This mixed blend was compressed 
directly in a 16 station rotary tableting machine using 9 
mm circular standard concave punches. As the process 
involved dry method of direct compression, the demerits of 
wet granulation were totally eliminated leading to energy 
saving. The experiment was designed in such a way that all 
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formulations were with three levels of polymer 
concentration
2
. 
Tablets Evaluation 
The prepared tablets were subjected to weight variation, 
hardness, friability, thickness, diameter, drug content, 
dissolution and stability studies. Twenty tablets were 
collectively and individually weighed in a digital balance 
and compared with the average weight of the tablet. 
Hardness tester was employed to evaluate the hardness and 
friabilator was used to study the friability nature of the 
tablet. The thickness and diameter of the tablets were 
evaluated by using digital vernier. Release rates of the 
tablets were evaluated by Invitro dissolution studies using 
USP Type I basket apparatus in 0.1 N HCl at 37° C ± 0.5° 
C with 100 rpm. Samples were drawn for upto 10 hours 
and sink conditions were appropriately maintained. 
Samples drawn were analysed for absorbance using UV 
Spectrophotometer at 270 nm to study the percentage drug 
release at a period of time. Similarly marketed product was 
also subjected to Invitro dissolution studies to compare the 
release profile with test formulations.  
Drug content was estimated by RP-HPLC method using 
Hypersil BDS C18 column. 295ml Acetonitrile and 705 ml 
of 0.02% v/v Trifluoroacetic acid was used as mobile 
phase with a flow rate of 1.0 ml/min.  UV detector was 
used to measure the absorbance at 270 nm. 
Drug- Polymer Compatibility was studied by using FT-IR 
and the spectra of pure drug, polymers & tablets were 
compared. The test formulation F3 was subjected to 
accelerated stability studies for 6 months at 40° C ± 2° C 
75% RH ± 5% RH and evaluated for physical and 
chemical properties. Zero order, First order, Higuchi, 
Hixson- Crowell and Korsmeyer – Peppas equations were 
applied to test formulation F3 for performing release rate 
studies
3
. 
RESULTS AND DISCUSSION 
Twelve formulations of extended release matrix tablets of 
Tramadol Hydrochloride 100 mg were prepared using 
Hydroxy propyl cellulose, Ethyl cellulose, Hydroxy propyl 
methyl cellulose K100 and chitosan as rate retarding 
polymers in various combinations and proportions (Table 
2). The total ratio of polymer combination was maintained 
at 1:1 with 20%, 30% and 40% concentrations (Table 3). 
All the formulations exhibited satisfactory physico-
chemical properties. The bulk density, tapped density, 
angle of repose, compressibility index and hausner’s ratio 
of the blend were in the range of 0.54 – 0.72, 0.63 – 0.82, 
22.2- 25.6, 12.20 – 16.66 and 1.14 -1.20 respectively 
(Table 1).  
 
Table 1: Evaluation of blend 
S. 
No 
Parameters F 1 F 2 F 3 F 4 F 5 F 6 F 7 F 8 F 9 F 10 F 11 F 12 
1 Angle of Repose 24.6 24.8 25.2 22.2 23.2 23.4 24.8 25.4 25.6 23.2 23.6 24.2 
2 Bulk Density 0.54 0.56 0.54 0.66 0.68 0.70 0.56 0.58 0.60 0.68 0.70 0.72 
3 Tapped Density 0.63 0.66 0.64 0.78 0.80 0.82 0.66 0.68 0.72 0.78 0.80 0.82 
4 Compressibility Index 14.28 15.15 15.63 15.38 15.00 14.63 15.15 14.70 16.66 12.82 12.50 12.20 
5 Hausner’s Ratio 1.16 1.18 1.19 1.18 1.18 1.17 1.18 1.17 1.20 1.15 1.14 1.14 
 
Table 2: Formulations 
S.N Ingredients (mg) F 1 F 2 F 3 F 4 F 5 F 6 F 7 F 8 F 9 F 10 F 11 F 12 
1 Tramadol HCl 100 100 100 100 100 100 100 100 100 100 100 100 
2 Dicalcium Phosphate 134 104 74 134 104 74 134 104 74 134 104 74 
3 Hydroxy Propyl Cellulose 30 45 60 30 45 60 - - - - - - 
4 HydroxyPropyl Methyl Cellulose K 100 - - - - - - 30 45 60 30 45 60 
5 Ethyl Cellulose 30 45 60 -- - - 30 45 60 - - - 
6 Chitosan - - - 30 45 60 - - - 30 45 60 
7 Colloidal Silicondioxide  3 3 3 3 3 3 3 3 3 3 3 3 
8 Magnesium Stearate 3 3 3 3 3 3 3 3 3 3 3 3 
                  Total (mg) 300 300 300 300 300 300 300 300 300 300 300 300 
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The weight variation of the tablets was within acceptable 
limits of ± 5%. The friability tests for formulations were 
satisfactory with values less than 1%. The tablets 
possessed good hardness in the range between 4.22 to 8.60 
kg/cm
3
.  The thickness and diameter of the tablets were 
within 4.14 mm to 4.45 mm and 9.01 mm to 9.03 mm 
indicating very less variation. Assay of the tablets were 
found to be in the range of 97.88 to 99.04% indicating 
good uniformity of drug content (Table 4).
 
Table 3: Design of Experiment 
Polymer 
Ratio 
1:1 1:1 1:1 1:1 
HPC : EC HPC : Chitosan HPMC K 100 : EC HPMC K 100 : Chitosan 
P 1 –20 % F 1 F 4 F 7 F 10 
P 2 –30 % F 2 F 5 F 8 F 11 
P 3 – 40% F 3 F 6 F 9 F 12 
 
Table 4: Evaluation of Tablets 
S.N Parameters F 1 F 2 F 3 F 4 F 5 F 6 F 7 F 8 F 9 F 10 F 11 F 12 
1 
Weight 
Variation % 
±2.0 ±2.2 ±1.8 ±3.8 ±4.4 ±4.6 ±3.4 ±3.6 ±3.5 ±4.7 ±4.5 ±4.4 
2 
Thickness in 
mm 
4.14 
±0.03 
4.22 
±0.04 
4.18 
±0.02 
4.30 
±0.04 
4.32 
±0.04 
4.40 
±0.02 
4.20 
±0.03 
4.26 
±0.03 
4.22 
±0.04  
4.45 
±0.02  
4.41 
±0.02 
4.37 
±0.02  
3 
Diameter in 
mm 
9.01 
±0.02 
9.02 
±0.01 
9.01 
±0.01 
9.03 
±0.01 
9.02 
±0.01 
9.01 
±0.02 
9.01 
±0.01 
9.01 
±0.02 
9.02 
±0.02 
9.03 
±0.03 
9.03 
±0.02 
9.02 
±0.01 
4 Friability % 
0.68 
±0.13 
0.62 
±0.12 
0.72 
±0.12 
0.80 
±0.10 
0.78 
±0.12 
0.82 
±0.14 
0.58 
±0.18 
0.60 
±0.22 
0.68 
±0.16 
0.76 
±0.14 
0.74 
±0.18 
0.80 
±0.16 
4 
Hardness in 
kg/cm
3
 
8.24 
±0.6 
8.40 
±0.4 
8.60 
±0.5 
5.48 
±0.4 
5.10 ± 
0.6 
4.80 
±0.4 
7.10 
±0.2 
6.88 
±0.3 
6.52 
±0.2 
4.22 
±0.4 
4.60 
±0.2 
4.52 
±0.3 
5 
Assay (Drug 
Content) 
98.72 
±0.66 
99.04 
±0.26 
99.12 
±0.18 
97.98 
±0.10 
98.14 
±0.28 
98.28 
±0.60 
99.06 
±0.58 
98.77 
±0.44 
98.90 
±0.22 
97.88 
±0.18 
98.04 
±0.34 
98.14 
±0.30 
 
Dissolution studies indicated that all the formulations 
retarded drug release at various levels. Formulation F3 
containing Hydroxy propyl cellulose
4-6 
and Ethyl 
cellulose
7-9 
at 40% concentration in the ratio of 1:1 gave a 
release for upto 10 hours (Table 5). 
 
Table 5: Dissolution Profile 
Sampling Time in hours 
Percentage Drug Released 
F 1 F 2 F 3 F 4 F 5 F 6 F 7 F 8 F 9 F 10 F 11 F 12 
Market 
Product 
1 50.18 37.90 33.16 57.69 53.08 36.11 58.74 51.12 38.45 59.14 57.90 51.38 30.54 
2 67.80 54.17 48.94 80.34 65.18 55.42 82.50 66.40 56.80 81.72 80.12 66.85 45.68 
4 86.15 77.12 68.07 97.92 85.05 78.81 97.54 86.55 76.15 96.12 95.48 86.57 70.51 
6 95.92 89.28 80.52 - 96.42 90.16 - 95.98 88.82 - - 96.10 83.92 
8 - 96.06 90.04 - - 96.38 - - 97.44 - - - 96.14 
10 - - 95.88 - - - - - - - - - - 
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Formulations F2 containing Hydroxy propyl cellulose + 
Ethyl cellulose
10,11 
at 30% concentration, F6 containing 
Hydroxy propyl cellulose + Chitosan
12-14 
at 40% 
concentration and F9 containing Hydroxy propyl methyl 
cellulose K100
15
 + Ethyl cellulose at 40% concentration 
gave a release for upto 8 hours and was comparable with 
marketed product which also gave a similar release for 
upto 8 hours. 
Formulations F1 containing Hydroxy propyl cellulose + 
Ethyl cellulose at 20% concentration, F5 containing 
Hydroxy propyl cellulose + Chitosan at 30% 
concentration, F8 containing Hydroxy propyl methyl 
cellulose K100 + Ethyl cellulose at 30% concentration and 
F12 containing Hydroxy propyl methyl cellulose K 100 + 
Chitosan at 40%  concentration gave a release for upto 6 
hours. 
Formulations F4 containing  Hydroxy propyl cellulose + 
Chitosan at 20% concentration, F7 containing Hydroxy 
propyl methyl cellulose K100 + Ethyl cellulose at 20% 
concentration, F10 containing  Hydroxy propyl methyl 
cellulose K100 + Chitosan at 20% concentration and F11 
containing Hydroxy propyl  methyl cellulose K100 + 
Chitosan at 30% concentration retarded the release for 
only upto 4 hours (Fig 1A ad 1 B). 
 
 
Figure 1A: Dissolution Profile 
 
 
Figure 1B: Dissolution Profile 
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Dissolution studies of the formulations indicated F3 as a 
better composition when compared to other formulations 
as it gave a maximum release for upto 10 hours. Release 
rate studies indicated that F3 followed Hixson crowell, 
Korsmeyer - Peppas and Higuchi equations with regression 
values of 0.9988, 0.9928 and 0.989 respectively. The First 
order and zero order plots gave regression values of 0.986 
and 0.9398 respectively. 
FT-IR studies performed on formulation F-3 indicated that 
there was no incompatibility between the drug Tramadol 
Hydrochloride and polymers Hydroxy propyl cellulose and 
Ethyl cellulose. The IR spectrum of Pure Drug, Polymers - 
Hydroxy propyl cellulose & Ethyl cellulose and Tablet F3 
were taken and investigated for any additional peaks. 
Characteristic prominent peaks at 1606, 1578 of pure drug 
– Tramadol Hydrochloride and peaks at 1604, 1579 of 
tablet F3 containing were visible in the spectrum. This 
clearly indicated that there is no incompatibility between 
drug and polymers (Fig 2). 
 
 
Figure 2A: FT-IR Spectrum of Pure Drug 
 
Figure 2B: FT-IR Spectrum of Polymer (HPC) 
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Figure 2C: FT-IR Spectrum of Polymer (EC) 
 
Figure 2D: FT-IR Spectrum of F 3 Tablet 
Accelerated stability studies performed on tablet F3 for a period of 6 months gave satisfactory results on physical and 
chemical properties indicating a stable formulation
16
 (Table 6). 
Table 6: Stability Studies of F3 
No. of 
Months 
Temperature in º 
C ± 2 º C 
Relative 
Humidity in % 
± 5 % 
Hardness in 
kg/cm3 
Thickness mm 
Diameter 
mm 
Friability % Assay in % 
Initial 40 75 8.60 4.17 9.01 0.72 99.12 
1 40 75 8.50 4.17 9.02 0.74 99.88 
3 40 75 8.40 4.17 9.01 0.78 98.94 
6 40 75 8.50 4.18 9.01 0.74 98.12 
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CONCLUSION  
The evaluation of formulations F1 to F12 indicate that F3 
containing Hydroxy propyl cellulose and Ethyl cellulose at 
40% concentration in the ratio of 1:1 is a suitable 
composition for preparing extended release matrix tablets 
of Tramadol Hydrochloride (100 mg) when long action is 
desired. Higuchi and Hixson crowell equation best defines 
the release pattern indicating dissolution and diffusion as 
the mechanisms. Korsmeyer – Peppas equation indicated 
the anomalous diffusion with an ‘n’ value of 0.46. Other 
formulations also retarded the drug release to various 
levels based on their proportions and concentration. The 
present study indicates that the polymers are directly 
proportional in retarding the drug release. 
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